La cadena de opciones muestra datos clave de las opciones de acciones de GlucoTrack a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para GlucoTrack..

GlucoTrack (NASDAQ:GCTK) Bolsa, Cadena de Opciones

GlucoTrack

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Movimiento de acciones

News

Intraday Update

Markets

Movers

Trading Ideas

ALUR

AUID

BHAT

BNTC

GCTK

INNV

MCVT

OUST

PNBK

PSTV

RVSB

TNMG

USAR

XHLD

Ouster sorprende con resultados mejores de lo esperado y sus acciones suben un 8,95%. Descubre las acciones que dominan el premercado.

Las acciones de Ouster (OUST) suben un 9%; Aquí están 20 acciones que se mueven en el premercado de EE.UU.

Pre-Market Outlook

AEON

ANIP

BBAI

BLRX

CFFI

DOYU

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

TSMC y otras acciones destacaron en el premercado tras reportar ganancias récord. Descubre los mayores ganadores y perdedores.

Acciones de Taiwan Semiconductor (TSM) suben alrededor del 5%; 20 acciones en movimiento en el premercado de EE.UU.

APLD

AZTR

CRKN

CVGW

GLAC

HSDT

LFWD

MASS

ORKA

QBTS

SGBX

VMAR

VRME

Descubre las acciones ganadoras y perdedoras en el premercado, con Vision Marine liderando un aumento del 45%.

Las acciones de Vision Marine (VMAR) se disparan un 45%; 20 acciones que se están moviendo en premercado

GlucoTrack Inc

Health Care

Press Releases

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Repurchase of Series A Warrants

General

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack to Participate in the Q3 Virtual Investor Summit

Glucotrack, Inc. Reminds Shareholders to Vote

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Aethlon Medical

Autonomix Medical

HeartBeam

Bluejay Diagnostics

Biomerica

Check-Cap

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Alpha Tau Medical

HeartSciences

SeaStar Medical Holding Corporation - Warrant

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

INVO Fertility

Lifeward

Spectral AI

NanoVibronix

ENDRA Life Sciences

Nuwellis

PAVmed

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Venus Concept

Catheter Precision

Screenshot 2025-06-09 at 5.40.14 PM

Movers & Shakers

Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management

Screenshot 2025-05-28 at 7.18.26 PM

Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives

Screenshot 2025-05-13 at 5.40.09 PM

First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients

Screenshot 2025-03-18 at 5.54.31 PM

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

Screenshot 2025-02-24 at 6.22.23 PM

Biotech

DXCM

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Screenshot 2025-01-06 at 6.34.13 PM

Advancing Clinical Studies, Meeting Regulatory Milestones, Strengthening Its Strategic Framework And More: The Past Year For Glucotrack, And What Lies Ahead

Screenshot 2024-12-03 at 7.43.04 PM

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

Screenshot 2024-10-03 at 5.30.47 PM

SENS

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Screenshot 2024-08-23 at 5.43.44 PM

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack&#39;s Plans To Transform The Continuous Glucose Monitoring Market

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Comments

GlucoTrack

GlucoTrack (GCTK) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL